20 September 2020: Meta-Analysis
Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis
Mengyin Ao 12ABCDEF , Ting Ding 12BF , Dan Tang 12E , Mingrong Xi 12E*DOI: 10.12659/MSM.925595
Med Sci Monit 2020; 26:e925595
Figure 2 (A) The risk of bias graph showing the reviewers’ assessment of the risk of bias for each included study; (B) risk of bias summary showing the reviewers’ assessment of the risk of bias presented as percentages for all the included studies.